Clinical Trial Update: Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy of L-Ornithine-L-Aspartate in cirrhotic patients with hepatic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Liver Cirrhosis

Drugs mentioned

• L-ornithine-L-aspartate (L-ornithine-L-aspartate)

Snippet

Sponsor: Aga Khan University | Conditions: Hepatic Encephalopathy | Phase 3 | Status: COMPLETED